Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr;21(4):e14557.
doi: 10.1111/iwj.14557. Epub 2023 Dec 21.

A systematic review of the efficacy, safety and satisfaction of regenerative medicine treatments, including platelet-rich plasma, stromal vascular fraction and stem cell-conditioned medium for hypertrophic scars and keloids

Alireza Jafarzadeh  1 , Arash PourMohammad  2 , Azadeh Goodarzi  1
Affiliations

A systematic review of the efficacy, safety and satisfaction of regenerative medicine treatments, including platelet-rich plasma, stromal vascular fraction and stem cell-conditioned medium for hypertrophic scars and keloids

Alireza Jafarzadeh et al. Int Wound J. 2024 Apr.

Abstract

The primary objective of this study is to examine the efficiency of various regenerative medicine approaches, such as platelet-rich plasma, cell therapy, stromal vascular fraction, exosomes and stem cell-conditioned medium, in the process of healing hypertrophic and keloid scars. Major databases including PubMed, Scopus and Web of Science were systematically searched, and based on the content of the articles and the inclusion and exclusion criteria, eight articles were selected. Out of these eight articles, there were two non-randomized clinical trial studies (25%), one randomized, single-blinded comparative study (12.5%), one retrospective clinical observational study (12.5%) and four randomized clinical trial studies (50%). We employed EndNote X8 and Google Sheets to conduct article reviews and extract relevant data. Following the review phase, the studies underwent analysis and categorization. In all eight reviewed studies, the effectiveness of regenerative medicine in treating hypertrophic scars and keloids has been proven. Out of these studies, five (62.5%) focused on the effectiveness of platelet-rich plasma, two study (25%) examined the effectiveness of stromal vascular fraction and one study (12.5%) explored the efficacy of stem cell-conditioned medium. In two studies (25%), the treatment methods were added to standard treatment, while in six studies (75%), regenerative medicine was used as the sole treatment method and compared with standard treatment. The use of these treatment methods did not result in any serious side effects for the patients. Regenerative medicine is an effective method with minimal side effects for the treatment of hypertrophic scars and keloids. It can be used as a monotherapy or in combination with other treatment methods. However, further studies are needed to thoroughly evaluate the effectiveness of all sub-branches of this method.

Keywords: platelet‐rich plasma; regenerative medicine; scar; systematic review.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
PRISMA statement of studied articles.
See this image and copyright information in PMC

References

    1. Joo SY, Cho YS, Lee SY, Seo CH. Regenerative effect of combined laser and human stem cell‐conditioned medium therapy on hypertrophic burn scar. Burns. 2023;49(4):870‐876. - PubMed
    1. Albalat W, Nabil S, Khattab F. Assessment of various intralesional injections in keloid: comparative analysis. J Dermatol Treat. 2022;33(4):2051‐2056. - PubMed
    1. Roohaninasab M, Khodadad F, Sadeghzadeh‐Bazargan A, et al. Efficacy of fractional CO(2) laser in combination with stromal vascular fraction (SVF) compared with fractional CO(2) laser alone in the treatment of burn scars: a randomized controlled clinical trial. Stem Cell Res Therapy. 2023;14(1):269. - PMC - PubMed
    1. Hewedy E‐SS, Sabaa BE‐SI, Mohamed WS, Hegab DS. Combined intralesional triamcinolone acetonide and platelet rich plasma versus intralesional triamcinolone acetonide alone in treatment of keloids. J Dermatol Treat. 2022;33(1):150‐156. - PubMed
    1. Neinaa YMEH, Elsayed TA, Mohamed DA, Elfar NN. Botulinum toxin and platelet rich plasma as innovative therapeutic modalities for keloids. Dermatol Ther. 2021;34(3):e14900. - PubMed

Publication types

Substances